Corcept Therapeutics (CORT) Tops Q2 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Needham Starts NeoVolta (NEOV) at Buy
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
Corcept Therapeutics Announces Second Quarter 2015 Results and Provides Corporate Update
August 5, 2015 4:06 PM EDTMENLO PARK, CA -- (Marketwired) -- 08/05/15 -- Corcept Therapeutics Incorporated (NASDAQ: CORT)
Per-share net loss in the second quarter narrows to $0.02, from $0.07 in the same period last year Excluding non-cash expenses, non-GAAP net income for the second quarter is $369,000, compared to a non-GAAP net loss of $5.4 million in the second quarter of 2014 Second quarter revenue is $12.0 million, compared to $5.9 million in the second quarter of 2014, a 104 percent increase 2015 revenue guidance is revised to $49 - $53 million Patient dosing continues in the efficacy portion of the company's Phase 1/2 trial... More